Metvix (PhotoCure).
Metvix is a photosensitive cream containing the methyl ester of 5-aminolevulinic acid, which has been developed and launched by PhotoCure in Sweden for the treatment of high-risk basal cell carcinoma and actinic keratosis.
Gardlo
Kerstin
K
Heinrich-Heine University, Moorenstrasse 5, 40225 Duesseldorf, Germany. kerstin.lang@med.uni-duesseldorf.de
Ruzicka
Thomas
T
D000287:Administration, Topical; D000622:Aminolevulinic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D006801:Humans; D009824:Ointments; D017319:Photosensitizing Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy / Q000378:metabolism; D013678:Technology, Pharmaceutical / Q000379:methods*
D009824:Ointments; D017319:Photosensitizing Agents; C475457:methyl 5-aminolevulinate; D000622:Aminolevulinic Acid